The new THREAD LIFT with approved design patent “TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG”
SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- Safe thread lifting without surgery, the most representative lifting method with various advantages TIMEMACHINE LIFE THREAD Recently, with the development of various lifting procedures, there are many methods to perfect a natural look, and many people are getting these procedures regularly due to lower cost. The most popular lifting procedure...
J INTS BIO, Novel Oral 4th Generation EGFR TKI ‘JIN-A02’ – Phase 1/2 IND approved by US FDA
- First patient expected in December 2022 SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small cell lung cancer (NSCLC). ...
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia
MIAMI and PERTH, Australia, Nov. 11, 2022 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufacturing facility of Pfizer (Perth)...
Oncoshot and Novotech Partner to Offer Cancer Data Insights
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun a partnership to enhance clinical trial management success. This collaborative partnership will grant exchange and insights into real-time population data between both organisations and their affiliated leading cancer research centres. Novotech, the leading Asia-Pacific biotech specialist...
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 11, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) today announced that Nona Biosciences, a subsidiary wholly owned by the Company, had entered into a license and collaboration agreement with ModernaTX, Inc. (NASDAQ: MRNA), a global biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting
- Oral presentation highlights preclinical data with ATG-031, an in-house discovered anti-CD24 monoclonal antibody, tracking to an investigational new drug (IND) filing in H1:2023 - Three poster presentations showcase preclinical data with three programs developed or discovered in-house, ATG-101, a PD-L1/4-1BB bispecific antibody (in Phase I studies), ATG-018, an ATR inhibitor (in...
Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting
SUZHOU, China, Nov. 11, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has presented two scientific posters at the 37th Society for Immunotherapy of Cancer's (SITC) Annual Meeting in Boston, MA, November 8-12, 2022. One related to...
Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo
HONG KONG, Nov. 10, 2022 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, is pleased to announce that, with over 500 physicians from 47 countries around the world, the event "Alma Academy" was successfully held in Dubai, UAE during November...
YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational...
ITRI Introduces Point-of-Care AI-DR Software for Rapid Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema
Point-of-Care AI-DR is the first AI-assisted system which can be integrated into handheld and desktop fundus cameras used to detect diabetic retinopathy and diabetic macular edema HSINCHU, Nov. 10, 2022 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech applied research institutions, today introduced Point-of-Care...
